Medtronic Diabetes has tasked the Harvey Mudd team with redesigning a novel continuous glucose monitoring device. Continuous glucose monitoring systems allow diabetics significantly more control over their glucose levels. Increased control raises their quality of life and has the potential to increase life spans. The objectives of the project are to reduce the power consumption, the start-up time, and the size of the device.